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Abstact: Accurate assessment of lymph node involvement is a
critical step in patients with non-small cell lung cancer in the
absence of distant metastases. The International Association for the
Study of Lung Cancer has proposed a new lymph node map, which
provides precise anatomic definitions for all intrathoracic lymph
nodes. Transoesophageal endoscopic ultrasound with fine-needle
aspiration and endobronchial ultrasound with transbronchial needle
aspiration are two minimally invasive techniques that are increas-
ingly implemented in the staging of non-small cell lung cancer.
Therefore, recognition of the proposed anatomic borders by these
techniques is very relevant for an accurate clinical staging. We here
discuss the reach and limits of endoscopic ultrasound in the precise
delineation and approach of the intrathoracic lymph nodes according
to the new lymph node map for the seventh edition of the tumor,
node, metastasis classification for lung cancer.
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Both transoesophageal endoscopic curved-linear ultra-sound with fine-needle aspiration (EUS-FNA) and endo-
bronchial curved-linear ultrasound with transbronchial needle
aspiration (EBUS-TBNA) are minimally invasive techniques
that are increasingly implemented in the diagnosis and stag-
ing of non-small cell lung cancer. Current lung cancer staging
guidelines advocate EUS-FNA and EBUS-TBNA, hereafter
referred to as “endoscopic ultrasound,” as an alternative for
surgical staging.1,2 When performed in an outpatient setting
under local anesthesia with or without mild sedation, EUS-
FNA and EBUS-TBNA allow the identification and real-time-
guided sampling of intrathoracic lymph nodes.3–5 Endoscopic
ultrasound has a high accuracy for demonstrating malignant
lymph node metastasis.3–11 By consequence, EUS-FNA or
EBUS-TBNA can avoid surgical staging procedures in a con-
siderable proportion of patients.12–14 The negative predictive
value remains a matter of concern. The cytoaspirations can be
false negative due to a detection, a sampling, or an interpretation
error. Because patients are selected on the clinical suspicion of
lymph node metastasis based on computed tomography (CT) or
F-18 fluorodeoxyglucose-positron emission tomography/CT im-
aging, negative EUS-FNA or EBUS-TBNA findings should be
confirmed by other methods. In general, a cervical mediastinos-
copy is advised in these conditions.1
The possibility of real-time tissue sampling is the reason
why curved linear rather than radial endoscopic ultrasound
represents an opportunity in the nodal staging of lung cancer.
The reach of EUS-FNA and EBUS-TBNA is partly overlapping
and partly complementary. EBUS-TBNA follows the large air-
ways, whereas EUS-FNA is excellent for the left and lower
mediastinal and paraoesophageal stations. When both tech-
niques are available, many of the mediastinal and hilar lymph
nodes can be reached for fine-needle aspiration (Figure 1). In
addition, with EUS-FNA, the left liver lobe, celiac trunc nodes,
and the left adrenal gland can be assessed.
In the new International Association for the Study of
Lung Cancer (IASLC) staging map,15 the anatomic borders of
the lymph node stations have been redefined. The precise
endoscopic delineation and sampling of these lymph nodes is
important to obtain an accurate clinical stage and for differ-
entiation between single and multiple level metastasis of the
lymph node stations. This article describes the new anatomic
landmarks and borders of the intrathoracic lymph node sta-
tions when visualized by either EUS-FNA or EBUS-TBNA.
BORDERS OF RELEVANCE AND ENDOSCOPIC
ULTRASOUND
The new IASLC lymph node map with its new ana-
tomic definitions contains notable changes relative to the
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Naruke and Mountain-Dresler modification of the American
Thoracic Society maps.15–17 The document15 provides precise
anatomic borders that should be taken into account also when
diagnostics and staging are performed with EUS-FNA and/or
EBUS-TBNA. With EUS, lymph nodes can be identified if
they are located in the vicinity of the esophagus. The nodes to
be identified with EUS are described in relation to vascular
structures (including the aorta, the azygos vein, the left
atrium, and the pulmonary artery) and the diaphragm.18,19
With EBUS, the ultrasound window angle is much smaller,
when compared with EUS (50–60 degree angle versus 150–
180 degree angle), which makes the visualization and iden-
tification of large vessels or ultrasound landmarks easier with
the latter. It has to be noted that endoscopic ultrasound is a
dynamic investigation and that the back and forward and the
rotational movement of the endoscope helps in the identification
of structures and landmarks. In contrast to EUS, a bronchoscopic
view into the airways is available during EBUS, which helps in
the identification of the lymph node stations.20
Station 1 nodes are located caudal to the inferior margin
of the cricoid but cranial to the incisura jugularis of the
sternum and cranial to the clavicles bilaterally. Therefore, the
supraclavicular nodes are also part of station 1. The latter can
be felt by a clinical examination when enlarged; however,
external ultrasound has shown to be useful for their localiza-
tion, identification, and puncture.21–24
Although the paratracheal part of station 1 can be
reached by EBUS-TBNA (1R/L; bilateral–the midline of the
trachea serves as the border) or EUS-FNA (1L; left), the
proposed anatomic borders cannot be recognized with endo-
scopic ultrasound. Because these nodes are localized ex-
trathoracic, an endoscopic approach is very unpractical. The
endoscopes are not stable for these very proximal stations
making interpretation and sampling technically difficult and
uncomfortable for the patient. Therefore, endoscopic ultra-
sound is of limited value for identification, delineation, and
sampling of the paratracheally located station 1 nodes.
From station 2 onward, the lymph nodes have an
intrathoracic localization. The inferior border of station 2L is
the transverse plane through the superior border of the aortic
arch (Figures 1 and 2). For 2R, the inferior border is then the
intersection of the caudal margin of the brachiocephalic vein
with the right-sided border of the trachea. The sagittal plane
at the left tracheal wall now makes the difference between
right and left. For endoscopic ultrasound node identification
and delineation, these revised definitions are important. Ul-
trasonographic discrimination between stations 2 and 4 is
evident, especially on the left side because the apex of the
aortic arch can readily be visualized by either EUS-FNA or
EBUS-TBNA. For the right-sided nodes, the margin simply
follows this transverse plane, which can serve as a surrogate
for the intersection of the trachea and brachiocephalic vein.
FIGURE 1. The different thoracic lymph node stations according to the newly proposed definition and the complementary
reach to take biopsies with endoscopic curved-linear ultrasound with fine-needle aspiration (EUS-FNA) (A; green nodes) or en-
dobronchial curved-linear ultrasound with transbronchial needle aspiration (EBUS-TBNA) (B; red nodes). Nodes that generally
cannot be sampled with endoscopic ultrasound are dark gray. The dot lines indicate anatomic borders that are important for
identification of the different lymph node stations by means of endoscopic ultrasound. Station 3a/p nodes are not indicated
on this image. Stations 5 and 6 can often be seen during endoscopic ultrasound, whereas sampling is hazardous because of
interposition of the great vessels.
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Discriminating left and right-sided nodes has clinical impli-
cations (N2 versus N3). In most of the cases, there is no
discussion about the position because the presence and the
size of the nodes as seen and measured on the CT scan also
help the endoscopist in the identification. However, it can be
that similarly enlarged nodes are found in this region and that
attention is needed for making the difference between N2 and
N3. As a general rule, it can be said that EUS-FNA can only
reach the left paratracheal lymph node stations. With EBUS-
TBNA, both stations can be approached while no clear
endoscopic or ultrasonographic landmarks are available to
discriminate left and right. Although the bronchoscopic im-
age helps during EBUS-TBNA, the left side of the trachea
never identifies as a straight plane. The large arteries (e.g.,
subclavian artery or the aortic arch) cannot help much be-
cause their position relative to that sagittal plane is variable.
In addition, the smaller ultrasonography window of EBUS-
TBNA also makes the visualization of the anatomic ultra-
sound landmarks is more limited.
Station 3 lymph nodes are defined with an anterior part
being the prevascular nodes and a posterior part being the
retrotracheal nodes. The craniocaudal extent goes for both
from the sternal notch down to the main carina. Although the
prevascular station 3A can be visualized with EBUS as laying
ventrally from the large vessels, there are no anatomic ultra-
sound landmarks to recognize the superior border of this
lymph node station. Sampling station 3A by endoscopic
ultrasound is impossible because of the interposition of the
large vessels (Figure 3). This contrasts with station 3P, which
is situated in between the pars membranacea of the trachea
and the vertebrae (Figure 3). It can be seen and sampled by
both EUS-FNA and EBUS-TBNA. Although there is no
ultrasound landmark for the superior margin of 3P either the
inferior margin being the main carina level corresponds with
the level of the main stem or left pulmonary artery during
EUS and can be seen as an anatomic structure during EBUS.
The margin between 3P and 2/4L is the left posterior tracheal
corner, which is identifiable by EUS-FNA or EBUS-TBNA.
The margin between 3P and 2/4R is the right posterior
tracheal corner that can be identified during EBUS-TBNA.
Station 4 lymph nodes are—as station 2 nodes—located
paratracheally but situated caudal to the transverse aortic arch
plane. The sagittal plane on the left side of the trachea
is—identical as discussed for the station 2 nodes—the margin
between left and right. By consequence, EUS-FNA in general
cannot approach a right paratracheal node. The comments
made to discriminate between 4R and 4L with EBUS-TBNA
are identical to those for stations 2. However, what can be
helpful for the endoscopist is that 4R nodes are situated
posterior to the superior vena cava and/or ascending aorta,
both presenting as large vessels with a vertical course, which
can be readily visualized by EBUS-TBNA. The inferior
margins of station 4 nodes have been redefined with impor-
tant clinical implications, also for endoscopic ultrasound. The
pleural reflection no longer serves as the border between
stations 4 and 10. Station 4L has now an inferior border
defined by the superior rim of the left main pulmonary artery
and a lateral margin defined by the aortopulmonary ligament
(Figures 1 and 4). With both EUS-FNA and EBUS-TBNA,
the cranial rim of the left main pulmonary artery can be
visualized. The aortopulmonary ligament is invisible for
ultrasound.
Station 4R’s inferior border has now been redefined as
the inferior border of the azygos vein. This new definition is
better because the anatomic margin being the pleural fold is
invisible for conventional or endoscopic imaging, whereas
the azygos vein is always visible. During EBUS-TBNA, it
typically presents in the right tracheobronchial corner as a
kidney-shaped vessel (Figure 5). By consequence, EBUS-
TBNA now can be used more confidently to discriminate
between mediastinal 4R and hilar 10R nodes. The 4R nodes
are by consequence characterized by their position just dor-
sally from the superior caval vein and/or aorta and medially
but not distally to the azygos vein.
FIGURE 2. Computed tomography (CT) scan (left panel) and endoscopic curved-linear ultrasound (EUS) image (right panel)
of lymph node (LN) station 2L. The inferior border of this lymph node is localized just cranial to the transverse plane through
the superior margin of the aortic arch. On the computed tomography (CT) scan image, the lymph node is situated immedi-
ately adjacent to the trachea and ventrally to the esophagus. During endoscopic curved-linear ultrasound (EUS), the lymph
node is found as a hypoechogenic sharp edged lesion just cranial to the transverse plane through the superior margin of the
aortic arch. Note: the right side of the endoscopic ultrasound image (also for Figures 3–8) corresponds with the cranial (supe-
rior) side in the patient.
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Station 5 lymph nodes are situated laterally to station
4L nodes with the ligamentum arteriosum as anatomic bor-
der. The inferior edge is similar for both, whereas the cranial
edge is not. Although 4L nodes are situated caudal to the
superior border of the aortic arch, station 5 nodes are located
caudal to the inferior border of the aortic arch (Figure 6).
Because the ligamentum arteriosum cannot be discerned by
means of ultrasound, the differentiation between 4L and 5 can
be difficult, especially when both stations contain suspect
lymph nodes. Station 5 nodes can be identified by EUS-FNA
and EBUS-TBNA although the latter is often more demand-
ing. Because of the interposition of aortic arch or pulmonary
artery, station 5 can only be punctured in selected patients
with enlarged nodes.
Station 6 mediastinal lymph nodes are located lateral to
the ascending aorta and aortic arch, in between the transverse
planes at the superior and inferior border of the aortic arch
(Figure 6). These nodes can most often be identified by
means of EUS-FNA, whereas this is not always possible with
EBUS-TBNA. The nodes in station 6 can only be punctured
by a transaortal approach.25
The subcarinal area or station 7 nodes have an inferior
border that is redefined. On the left side, this is the superior
border of the lower lobe bronchus, and on the right side, this
is the inferior border of the intermediate bronchus. The lymph
nodes in this station can be seen and biopsied by both
EUS-FNA and EBUS-TBNA. Formerly, an anterior and pos-
terior part of this node was recognized. This was meaningful
because a cervical mediastinoscopy cannot reach the poste-
rior part of this station. With EUS-FNA and EBUS-TBNA,
the entire subcarinal area can be approached. Although iden-
tification of the nodes in this station is easy for both EUS-
FIGURE 3. Computed tomography
(CT) scan and endobronchial
curved-linear ultrasound (EBUS) im-
age of lymph node stations 3A and
3P. Station 3P (upper panel) is lo-
cated just behind the trachea (left
panel) and reaches from the apex of
the lung down to the main carina.
3P can be identified and sampled
with endobronchial curved-linear
ultrasound (EBUS) (right panel) or
endoscopic curved-linear ultrasound
(EUS). There are no ultrasound land-
marks to identify the upper border
of this lymph node station. Station
3A (lower panel) is on the right situ-
ated anterior to the superior vena
cava (SVC) and on the left anterior
to the left carotid artery. Although
3A can be seen with endobronchial
curved-linear ultrasound (EBUS),
sampling is impossible.
FIGURE 4. Computed tomography
(CT) scan and endoscopic curved-
linear ultrasound (EUS) image of
lymph node station 4L. Both the su-
perior and inferior border of lymph
node station 4L can be accurately
identified by endoscopic ultrasound
(right panel) being the transverse
planes through the superior border of
the aorta (Ao) and left pulmonary
artery, respectively (LAP). The lateral
border of this station being the liga-
mentum arteriosum is invisible both
on computed tomography (CT) and
during endoscopic ultrasound.
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FNA (the nodes lay just dorsally to the origin of the left
pulmonary artery and cranial to the left atrium) and EBUS-
TBNA (by means of the endoscopic view), the delineation of
the inferior border by means of endoscopic ultrasound is,
however, not easy (Figure 7). With EUS-FNA, the left atrium
is generally seen as the anatomic border above which the
FIGURE 5. Computed tomography
(CT) scan, endobronchial curved-
linear ultrasound (EBUS) image of
lymph node station 4R, and the cor-
responding endobronchial view.
The lower border of the azygos vein
is an ultrasound landmark structure
making the difference between 4R
and 10R nodes. This vein is localized
in the tracheobronchial corner on
the right and is typically kidney
shaped during identification with
endobronchial curved-linear ultra-
sound (EBUS) (upper panel, right).
The lymph nodes are then visual-
ized just superior to and/or medially
from the azygos vein as hypoecho-
genic sharp edged structures lying
just posterior to the superior vena
cava (SVC) or aorta. The puncture
for endobronchial curved-linear ul-
trasound with transbronchial needle
aspiration (EBUS-TBNA) is classically
performed at or just above the tra-
cheobronchial corner, leaving be-
hind a small bloody puncture lesion
(lower panel-left).
FIGURE 6. Computed tomography
(CT) scan and endoscopic curved-
linear ultrasound (EUS) images of
lymph node stations 5 (left upper
panel; white arrow) and 6 (left
lower panel, white arrow). The infe-
rior border of station 5 is the supe-
rior rim of the left pulmonary artery
(right upper panel). The inferior
border of the aortic arch is the fron-
tier between stations 5 and 6. The
superior border of station 6 (right
lower panel) is the transverse plane
through the superior border of the
aortic arch. Although these stations
and their borders can be identified
by means of EUS and endobronchial
curved-linear ultrasound (EBUS),
sampling without transpassing the
great vessels is often impossible.
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subcarinal nodes are situated, although this is with the new
definition probably too restrictive. The relation of the left
atrium or pulmonary artery to the bronchus intermedius and
the left lower lobe bronchus, the latter being the newly
defined inferior borders of station 7, can be variable. With
EBUS-TBNA, the delineation of the inferior border is possi-
ble because this investigation allows a simultaneous broncho-
scopic view of the bronchial tree although there are no
distinct corresponding ultrasound landmarks.
Stations 8 and 9 are the paraoesophageal and pulmo-
nary ligament nodes, respectively, and are situated inferior to
the inferior margins of station 7 lymph nodes. The superior
border of these lymph nodes is as such defined by the inferior
margin of the subcarinal area. Station 8 nodes are located
along the left atrium, whereas station 9 nodes are lying within
the pulmonary ligament. Although the latter is a structure that
cannot be seen with endoscopic ultrasound, station 9 nodes
are located just cranial to the diaphragm, which is readily
identifiable with EUS-FNA. Stations 8 and 9 lymph nodes
can be thus approached by means of EUS-FNA. Occasion-
ally, station 8 nodes can be found by EBUS-TBNA. How-
ever, and as suggested above, one has to take into account the
inferior stretch of the subcarinal nodes making this station in
addition to station 9 becomes invisible for EBUS-TBNA.
When performing EUS-FNA, one cannot confuse a lesion or
lymph node with the esophagus. When performing EBUS-
TBNA, the esophagus can be seen as a multilayered structure
with a hyperechogenic line in the middle corresponding with
air not to be misinterpreted as a lymph node (Figure 8). The
discrimination between the left- and right-sided nodes is the
midline. Although no formal ultrasound characteristics for
the midline are available, the relative position of the endo-
scope to the descending aorta can help.
The hilar nodes of station 10 are situated immediately
adjacent to the mainstem bronchus but caudal to the inferior
border of azygos vein on the right and superior rim pulmo-
nary veins and artery on the left. These nodes can be seen and
sampled by EBUS-TBNA. The inferior margin of station 10R
is the interlobar region. There is no unique ultrasound feature
that defines that border, but because a bronchoscopic view is
available during EBUS-TBNA, the secondary carina or the
upper lobe split off can serve as surrogate here. EUS-FNA
has been thought to be unable to see and sample hilar stations.
However, there is no doubt that in certain cases, station 10
nodes located medially from the main stem bronchi can be
assessed. Endoscopists should be aware of this because mis-
interpretation could lead to overstaging.26 Once the secondary
carina is reached, station 11 lymph nodes (or interlobar
nodes) are encountered. From this station on, the nodes can
only be approached by EBUS-TBNA and not by EUS-FNA.
These nodes are located just underneath the mucosa of the
secondary carina on the left. There is a division between 11s
and 11i on the right side. The former indicate the nodes
between upper lobe and intermediate bronchus, the latter are
situated in between middle and lower lobe ultrasound land-
marks are not available; however, the synchronous endo-
scopic view enables the identification of the relevant lobe
split offs.
Once the lobar bronchi originate, then station 12 is
reached. Again, there are no unique ultrasound borders, only
the endoscopic view can help for guidance. Stations 13 and
14 are segmental and subsegmental nodes. Frequently, the
EBUS-TBNA endoscope is too large to approach the seg-
ments and subsegments and their lymph nodes.
DISCUSSION AND CONCLUSION
Accurate assessment of the mediastinal and hilar lymph
nodes is important for patients with non-small cell lung
cancer in whom no metastasis are found outside the thorax or
in the pleural space or contralateral lung.1,27 The reason is
that lymph node metastases have an impact on the choice of
FIGURE 7. The subcarinal station shown on CT scan (left panel) can easily be visualized with both endoscopic curved-linear
ultrasound (EUS) (right panel) but of course also with endobronchial curved-linear ultrasound (EBUS). During endoscopic
curved-linear ultrasound (EUS), the subcarinal station identifies as a round, hypoechogenic sharply edged structure located in
between the esophagus and the pulmonary artery. The upper rim of this artery corresponds in general with the main carina
and is helpful during endoscopic curved-linear ultrasound (EUS). The main carina is visualized by means of endoscopy during
endobronchial curved-linear ultrasound (EBUS). The inferior border is the roof of the lower lobe bronchus on the left and the
bottom of the bronchus intermedius on the right. There are no unique ultrasound features that correspond to this definition
although endoscopy during endobronchial curved-linear ultrasound (EBUS) is helpful.
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therapy and prognosis. The correct identification of the
lymph node stations is crucial to avoid overstaging and
understaging. In particular, a correct mediastinal lymph
node staging refers not only to making a difference be-
tween N0-1, N2, or N3 disease but also to a good assess-
ment of the extent of lymph node metastasis (single station
versus multiple stations).
In this document, we describe and discuss the reach and
limits of endoscopic ultrasound in the precise delineation and
approach of thoracic lymph nodes according to the new
tumor, node, metastasis-classification of lung cancer and the
new definition of IASLC thoracic lymph node map.15 We are
aware that the recognition of the borders of the different
lymph node stations by endoscopic ultrasound is subjected to
individual variations, but the findings described in this doc-
ument should apply to a majority of the patients and have
been summarized in Table 1.
Although translation of the new anatomic definitions in
ultrasound landmarks is straight forward for a large number
of stations, cautiousness is warranted in several instances.
The reason is that the proposed IASLC-definition is based on
anatomic/surgical data that were correlated with CT scan
data, whereas ultrasound data were not considered. When the
proposed borders are to be identified with either EUS-FNA or
EBUS-TBNA, a number of elements should be taken into
account. Although we advice to perform EUS and EBUS
investigations in a standardized manner by seeking all nodes
detectable from either the esophagus or large airways to
detect potential metastases, it is clear that the CT scan (or
F-18 fluorodeoxyglucose-positron emission tomography/CT
scan) will always guide the endoscopist to find the nodes. It
quite often happens that a single mediastinal lymph node
station is suspect by its size and that it can be reached easily.
In those cases, there can be no discussion about the lymph
node station as it is defined by its unique localization on the
CT scan.
However, when nodes are identified in multiple sta-
tions, the endoscopist has the task and responsibility to
provide a correct identification and sampling. For quite a
number of lymph nodes, these margins can be recognized; for
example, there is the transverse plane on top of the aortic arch
to make the difference between stations 2 and 4. Similarly,
the azygos vein, which is easily identified by means of EBUS,
is a recognizable border making the difference between 4 and
10. However, in some cases, delineation of the lymph node
station by ultrasound is not unambiguous. Because there are
no ultrasound landmarks corresponding with the sagittal
plane on the left tracheal border, making the difference
between N2 and N3 nodes can be a challenge. With EBUS-
TBNA and also with EUS-FNA, hilar station 10 nodes that
are located medially from the main bronchi can be overinter-
preted as subcarinal nodes, which would implicate an upstag-
ing of the patient with important therapeutic and prognostic
consequences.26 Therefore, we advise that endoscopists make
a detailed and systematic protocol of the EUS or EBUS
procedure and document it at least with relevant ultrasound
FIGURE 8. Typical computed to-
mography (CT) images (left upper
and lower panel) of node stations
8R and 8L. The ultrasound visualiza-
tion of these stations was performed
here with the endoscopic curved-
linear ultrasound (EUS) scope (8R:
right upper panel). There are no
specific ultrasound landmarks to
identify the borders of these lymph
node stations although the inferior
margin of both stations 8 and 9 is
the diaphragm, which is readily
identifiable with endoscopic curved-
linear ultrasound with fine-needle
aspiration (EUS-FNA) but not endo-
bronchial curved-linear ultrasound
with transbronchial needle aspira-
tion (EBUS-TBNA). The esophagus is
visualized by endobronchial curved-
linear ultrasound (EBUS) as a longi-
tudinal structure with a hyperecho-
genic band (right lower panel).
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images or video’s together with the correlating images on the
CT scan. It is important that, in case of doubt, a surgical
verification of the endoscopic findings should be considered.
Not all borders have the same importance, for example,
the difference between stations 8 and 9 will virtually never
have therapeutic implications. The same holds for the inferior
border of station 7, which is not recognizable with EUS-FNA,
and probably hardly with EBUS-TBNA. Similarly, the dif-
ference between stations 10 and 11 is not relevant for clinical
staging; however, it can have consequences for the extent of
resection needed because involvement of station 10 will
probably result in a higher rate of pneumonectomy.
Another issue is the risk for false-positive clinical
staging in case of a centrally located lung tumor. It could be
that during mediastinal sampling, regardless the technique,
tumor instead of lymph node is taken by accident. Although
this is probably very rare, its prevalence remains poorly
documented in the literature.28
Areas of continuing controversy regarding the lymph
nodes metastases, outside the above mentioned problems,
include the assessment of intranodal versus extranodal dis-
ease, the detection (and significance) of isolated tumor cells
and micrometastasis, and the need for systematic lymph node
dissection versus a less extensive lymph node sampling.
In conclusion, recognition of the new anatomic borders
by EUS-FNA and EBUS-TBNA is relevant to correctly stage
the patient with lung cancer. Although these borders and thus
the exact lymph node stations can be identified in a large
number of cases, there is a degree of uncertainty in some. The
clinician should be aware of these when making a clinical
interpretation.
REFERENCES
1. Detterbeck FC, Jantz MA, Wallace MB, Vansteenkiste J, Silvestri GA.
Invasive mediastinal staging of lung cancer. ACCP evidence based
clinical practice guidelines (2nd edition). Chest 2007;132:202S–220S.
2. De Leyn P, Lardinois D, Van Schil PE, et al. ESTS guidelines for
preoperative lymph node staging for non-small cell lung cancer. Eur
J Cardiothorac Surg 2007;32:1–8.
3. Herth FJ, Rabe KF, Gasparini S, Annema JT. Transbronchial and
transoesophageal (ultrasound-guided) needle aspirations for the analysis
of mediastinal lesions. Eur Respir J 2006;28:1264–1275.
4. Gu P, Zhao YZ, Jiang LY, Zhang W, Xin Y, Han BH. Endobronchial
ultrasound-guided transbronchial needle aspiration for staging of lung can-
cer: a systematic review and meta-analysis. Eur J Cancer 2009;45:1389–1396.
5. Micames CG, McCrory DC, Pavey DA, Jowell PS, Gress FG. Endoscopic
ultrasound-guided fine-needle aspiration for non-small cell lung cancer
staging: a systematic review and metaanalysis. Chest 2007;131:539–548.
6. Eloubeidi MA, Cerfolio RJ, Chen VK, Desmond R, Syed S, Ojha B.
Endoscopic ultrasound-guided fine needle aspiration of mediastinal
lymph node in patients with suspected lung cancer after positron emis-
sion tomography and computed tomography scans. Ann Thorac Surg
2005;79:263–268.
7. Annema JT, Hoekstra OS, Smit EF, Veselic M, Versteegh MI, Rabe KF.
Towards a minimally invasive staging strategy in NSCLC: analysis of PET
positive mediastinal lesions by EUS-FNA. Lung Cancer 2004;44:53–60.
8. Bauwens O, Dusart M, Pierard P, et al. Endobronchial ultrasound and
value of PET for prediction of pathological results of mediastinal hot
spots in lung cancer patients. Lung Cancer 2008;61:356–361.
9. Rintoul RC, Tournoy KG, El DH, et al. EBUS-TBNA for the clarifica-
tion of PET positive intra-thoracic lymph nodes-an international multi-
centre experience. J Thorac Oncol 2009;4:44–48.
10. Wallace MB, Pascual JM, Raimondo M, et al. Minimally invasive
endoscopic staging of suspected lung cancer. JAMA 2008;299:540–546.
11. Herth FJ, Eberhardt R, Krasnik M, Ernst A. Endobronchial ultrasound-
guided transbronchial needle aspiration of lymph nodes in the radiolog-
ically and positron emission tomography-normal mediastinum in pa-
tients with lung cancer. Chest 2008;133:887–891.
12. Tournoy KG, De Rijck F, Vanwalleghem LR, et al. Endoscopic ultra-
sound reduces surgical mediastinal staging in lung cancer: a randomized
trial. Am J Respir Crit Care Med 2008;177:531–535.
13. Annema JT, Versteegh MI, Veselic M, Voigt P, Rabe KF. Endoscopic
ultrasound-guided fine-needle aspiration in the diagnosis and staging of lung
cancer and its impact on surgical staging. J Clin Oncol 2005;23:8357–8361.
14. Yasufuku K, Chiyo M, Koh E, et al. Endobronchial ultrasound guided
transbronchial needle aspiration for staging of lung cancer. Lung Cancer
2005;50:347–354.
15. Rusch VW, Asamura H, Watanabe H, Giroux DJ, Rami-Porta R,
Goldstraw P. The IASLC Lung Cancer Staging Project: a proposal for a
new international lymph node map in the forthcoming seventh edition of
the tnm classification for lung cancer. J Thorac Oncol 2009;4:568–577.
16. Naruke T, Suemasu K, Ishikawa S. Lymph node mapping and curability
at various levels of metastasis in resected lung cancer. J Thorac Car-
diovasc Surg 1978;76:833–839.
17. Mountain CF, Dresler CM. Regional lymph node classification for lung
cancer staging. Chest 1997;111:1718–1723.
18. Annema JT, Rabe KF. EUS in non-small cell lung cancer. In RH Hawes, P
Fockens (Eds.), Endosonography. Philadelphia: WB Saunders, 2006:61–72.
19. Kramer H, van Putten JW, Douma WR, Smidt AA, van Dullemen HM,
Groen HJ. Technical description of endoscopic ultrasonography with
fine-needle aspiration for the staging of lung cancer. Respir Med 2005;
99:179–185.
20. Herth FJ, Krasnik M, Yasufuku K, Rintoul RC, Ernst A. Endobronchial
ultrasound-guided transbronchial needle aspiration. J Bronchol 2006;13:
84–91.
TABLE 1. Endoscopic Ultrasonography According to the
Proposed Lymph Node Map Definition in the Forthcoming
Seventh Edition of the TNM Classification for Lung Cancer
Margin Identifiable
EUS-FNA EBUS-TBNA
Superior Inferior Superior Inferior
1    
2RL    
3a    
3p    
4R    
4L    
5   () ()
6   () ()
7    
8RL    
9RL    
10    
11    
12–13–14    
The different thoracic lymph node stations and the ability of EUS-FNA and
EBUS-TBNA to identify the newly defined upper and lower anatomical borders. “”
means that the newly defined lymph node station borders cannot be found by means of
endoscopic ultrasound, “” means that the newly defined lymph node station borders
can be found by means of endoscopic ultrasound, and “()” means that the newly
defined lymph node station borders can be found by means of endoscopic ultrasound,
but that the nodes themselves are often out of the visibility range of the endoscope. Note
that visualization of the newly defined borders of the nodes does not necessarily mean
the nodes can be sampled by fine-needle aspiration, as is the case for nodes in stations
5 and 6.
EUS-FNA, endoscopic curved-linear ultrasound with fine-needle aspiration; EBUS-
TBNA, endobronchial curved-linear ultrasound with transbronchial needle aspiration;
TNM, tumor, node, metastasis.
Journal of Thoracic Oncology • Volume 4, Number 12, December 2009 Endoscopic and Endobronchial Ultrasonography
Copyright © 2009 by the International Association for the Study of Lung Cancer 1583
21. van Overhagen H, Brakel K, Heijenbrok MW, et al. Metastases in
supraclavicular lymph nodes in lung cancer: assessment with palpation,
US, and CT. Radiology 2004;232:75–80.
22. Kumaran M, Benamore RE, Vaidhyanath R, et al. Ultrasound guided
cytological aspiration of supraclavicular lymph nodes in patients with
suspected lung cancer. Thorax 2005;60:229–233.
23. Sihoe AD, Lee TW, Ahuja AT, Yim AP. Should cervical ultrasonogra-
phy be a routine staging investigation for lung cancer patients with
impalpable cervical lymph nodes? Eur J Cardiothorac Surg 2004;25:
486–491.
24. Prosch H, Strasser G, Sonka C, et al. Cervical ultrasound (US) and
US-guided lymph node biopsy as a routine procedure for staging of lung
cancer. Ultraschall Med 2007;28:598–603.
25. von Bartheld MB, Rabe KF, Annema JT. Transaortic EUS-guided FNA
in the diagnosis of lung tumors and lymph nodes. Gastrointest Endosc
2009;69:345–349.
26. Dooms C, Vansteenkiste J, Van RD, De LP. Esophageal ultrasound-
controlled fine needle aspiration for staging of mediastinal lymph nodes
in patients with resectable lung cancer: do we always see the reality?
J Thorac Oncol 2009;4:1043–1045.
27. Silvestri GA, Gould MK, Margolis ML, et al. Noninvasive staging of
non-small cell lung cancer: ACCP evidenced-based clinical practice
guidelines (2nd edition). Chest 2007;132,178S–201S.
28. Annema JT, Versteegh MI, Veselic M, et al. Endoscopic ultrasound
added to mediastinoscopy for preoperative staging of patients with lung
cancer. JAMA 2005;294:931–936.
Tournoy et al. Journal of Thoracic Oncology • Volume 4, Number 12, December 2009
Copyright © 2009 by the International Association for the Study of Lung Cancer1584
